Total Payments
$1,224
2024 Payments
$506.09
Companies
18
Transactions
71
Medicare Patients
981
Medicare Billing
$30,697
Payment Breakdown by Category
Food & Beverage$1,224 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,224 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $289.76 | 11 | $0 (2024) |
| ABBVIE INC. | $261.28 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $174.62 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $92.08 | 5 | $0 (2023) |
| PFIZER INC. | $76.45 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $56.81 | 4 | $0 (2024) |
| Novo Nordisk Inc | $48.18 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $44.48 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $30.40 | 2 | $0 (2024) |
| Lilly USA, LLC | $26.23 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $506.09 | 23 | AstraZeneca Pharmaceuticals LP ($240.90) |
| 2023 | $378.75 | 24 | ABBVIE INC. ($144.74) |
| 2022 | $63.59 | 4 | GlaxoSmithKline, LLC. ($63.59) |
| 2021 | $275.99 | 20 | Merck Sharp & Dohme Corporation ($69.82) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $89.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Hematology | ||||||
| 07/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Biological | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Cardiovascular | ||||||
| 03/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 262 | 281 | $8,632 | $4,409 |
| 2022 | 7 | 119 | 124 | $4,199 | $2,385 |
| 2021 | 4 | 199 | 218 | $17,663 | $9,048 |
| 2020 | 8 | 401 | 490 | $40,949 | $14,854 |
Total Patients
981
Total Services
1,113
Medicare Billing
$30,697
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 14 | 14 | $2,137 | $1,957 | 91.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 85 | $1,346 | $646.85 | 48.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 17 | $1,249 | $598.84 | 47.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 50 | $2,416 | $584.35 | 24.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 38 | 39 | $771.81 | $371.28 | 48.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 49 | 52 | $346.32 | $161.72 | 46.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $306.90 | $60.76 | 19.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 13 | $59.54 | $28.60 | 48.0% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 11 | 11 | $1,679 | $1,552 | 92.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 17 | 17 | $821.27 | $223.42 | 27.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 23 | 23 | $364.09 | $176.47 | 48.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 15 | $296.85 | $143.34 | 48.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 20 | $672.46 | $115.19 | 17.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 11 | 11 | $241.92 | $114.99 | 47.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 26 | 27 | $123.66 | $60.22 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 117 | $12,870 | $5,970 | 46.4% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 57 | 62 | $3,906 | $2,804 | 71.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 14 | $680.00 | $217.72 | 32.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 24 | 25 | $207.48 | $56.25 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 257 | 309 | $33,990 | $12,371 | 36.4% |
| 87804 | Detection test for influenza virus | Office | 2020 | 27 | 54 | $1,998 | $877.20 | 43.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $2,080 | $748.29 | 36.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 25 | 28 | $560.00 | $209.36 | 37.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 12 | 12 | $560.00 | $208.58 | 37.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 25 | 27 | $1,215 | $196.62 | 16.2% |
About Anthony Rodriguez
Anthony Rodriguez is a Family healthcare provider based in Warren, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1770020521.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Rodriguez has received a total of $1,224 in payments from pharmaceutical and medical device companies, with $506.09 received in 2024. These payments were reported across 71 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,224).
As a Medicare-enrolled provider, Rodriguez has provided services to 981 Medicare beneficiaries, totaling 1,113 services with total Medicare billing of $30,697. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Warren, AR
- Active Since 01/31/2017
- Last Updated 02/02/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1770020521
Products in Payments
- FARXIGA (Drug) $183.29
- VRAYLAR (Drug) $131.11
- TRELEGY ELLIPTA (Drug) $125.44
- AIRSUPRA (Drug) $91.18
- UBRELVY (Drug) $84.64
- BELSOMRA (Drug) $76.06
- ELIQUIS (Drug) $75.44
- XIFAXAN (Drug) $56.81
- ANORO ELLIPTA (Drug) $49.18
- Ozempic (Drug) $33.86
- LEQVIO (Drug) $33.22
- QULIPTA (Drug) $32.38
- MOUNJARO (Drug) $26.23
- Veozah (Drug) $23.17
- ACCRUFER (Drug) $18.02
- PREVNAR 13 (Biological) $17.84
- JANUVIA (Drug) $16.02
- Cologuard Collection Kit (Device) $15.40
- LOKELMA (Drug) $15.29
- FreeStyle Libre 2 (Device) $15.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Warren
Mrs. Brittney Price, Msn, Rn, Fnp-Bc, MSN, RN, FNP-BC
Family — Payments: $11,179
Family $11,179
Laura Cesario, Fnp-Bc, FNP-BC
Family — Payments: $7,902
Family $7,902
Elisheva Ellenberg
Family — Payments: $7,042
Family $7,042
Victoria Dennis, Fnp, FNP
Family — Payments: $6,900
Family $6,900
Rosalie Patero
Family — Payments: $4,949
Family $4,949
Soodad Rabban, Fnp, FNP
Family — Payments: $4,307
Family $4,307